SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Biocon informs about institutional investor meet

10 Jun 2021 Evaluate

Pursuant to Regulation 30 (6) of the SEBI LODR Regulations, 2015, Biocon has informed that a meeting was conducted with Institutional Investor / Research Analysts on 9th June 2021. Further details of the meeting are attached.

The above information is a part of company’s filings submitted to BSE.

Biocon Share Price

417.20 -1.00 (-0.24%)
02-Jul-2026 10:37 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1874.80
Dr. Reddys Labs. 1345.00
Cipla 1458.25
Zydus Lifesciences 1106.90
Lupin 2392.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: